Treatments

WHO to call for urgent, high-level action to address global problem of antimicrobial resistance

Fri, 2024-09-20 17:39 — mike kraft

WHO at UNGA: Call for urgent, high-level action to address global scourge of antimicrobial resistance The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges, and invest in global public health, at meetings throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79), to be held in New York from 20 to 30 September 2024.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about WHO to call for urgent, high-level action to address global problem of antimicrobial resistance
Log in or register to post comments

Common diabetes drug may lower rate of long COVID --study

Fri, 2024-09-20 10:36 — mike kraft

Common diabetes drug linked to lower rate of long COVID Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care suggests the drug can lower the risk of developing long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in diabetics. CIDRAP

...

Metformin lowers blood sugar and is most commonly prescribed as a first-line treatment for type 2 diabetes. The drug also is prescribed off-label for weight loss and other metabolic conditions.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about Common diabetes drug may lower rate of long COVID --study
Log in or register to post comments

U.S. ranks last on key health care measures compared with other high-income nations

Thu, 2024-09-19 10:50 — mike kraft

US ranks last on key health care measures compared with other high-income nations, despite spending the most, report says | CNN The US spends more on health care than any other high-income country, but a new report suggests that “Americans are sicker, die younger and struggle to afford essential health care.” Jacqueline Howard CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about U.S. ranks last on key health care measures compared with other high-income nations
Log in or register to post comments

Machine-learning to allocate monoclonal antibody treatment in pandemic could cut hospital cases by a third --study

Wed, 2024-09-18 13:30 — mike kraft

Machine-learning monoclonal antibody allocation in pandemic could cut hospital cases by a third If drugs and medical treatments are in short supply during a pandemic, a new model shows how machine learning can help decide how to distribute medicines and reduce hospitalizations by up to 27%. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Analysis: Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Doubts Remain

Wed, 2024-09-11 13:00 — mike kraft

Mpox And Cholera Outbreaks Underscore Importance Of Gavi’s African Vaccine Initiative - But Can It Ensure Equity? - Health Policy Watch Back in June, the vaccine platform, Gavi, launched the African Vaccine Manufacturing Accelerator (AVMA), together with the African Union and Africa Centres Health Policy Watch

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Cholera Deaths Soar Worldwide as Fatalities spiked 71 percent last year, far outpacing the 13 percent rise in cases--WHO

Wed, 2024-09-11 12:51 — mike kraft

The cholera outbreaks spreading across the globe are becoming more deadly. Deaths from the diarrheal disease soared last year, far outpacing the increase in cases, according to a new analysis by the World Health Organization.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Explainer: Guidance for dealing with COVID as colder weather begins in Northern Hemisphere.

Thu, 2024-09-05 11:00 — mike kraft

New COVID vaccine for 2024, isolation guidelines, free tests and more questions, answered Tested positive for COVID in 2024? Here's what to know about isolation, testing, new vaccines and more. CBS News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about Explainer: Guidance for dealing with COVID as colder weather begins in Northern Hemisphere.
Log in or register to post comments

Analysis: Journalists' articles often didn't communicate uncertainty of evidence on unproven COVID drugs

Tue, 2024-09-03 19:52 — mike kraft

Analysis: Journalists often didn't communicate uncertainty of evidence on unproven COVID drugs Scientific evidence of the efficacy of the unproven COVID-19 therapies hydroxychloroquine, remdesivir, and convalescent plasma was often presented in US news stories in the first months of the pandemic, but scientific uncertainty was commonly omitted and only rarely appeared in headlines or ledes, with possible implications for public health, researchers reported yesterday in JMIR Infodemiology. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

More information and background on new COVID vaccine approved today

Thu, 2024-08-22 17:48 — mike kraft

New coronavirus vaccines are now approved. Here’s what to know. The mRNA coronavirus vaccines from Pfizer-BioNTech and Moderna tailored for the KP.2 variant could be available within a week. Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about More information and background on new COVID vaccine approved today
Log in or register to post comments

Analysis: Antiviral TPOXX, used for mpox no better than placebo, NIH

Fri, 2024-08-16 12:17 — mike kraft

Antiviral used for mpox no better than placebo, NIH says Just as mpox is declared a global health emergency, the antiviral tecovirimat is found to be no better than placebo against it. Jason Mast STAT

The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial.

The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its wide use during the 2022 and 2023 outbreaks in the U.S. and Europe.

Country / Region Tags:

Africa

Democratic Republic of the Congo

General Topic Tags: